We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$22.8B
AUM Growth
-$4.8M
Cap. Flow
+$69.6M
Cap. Flow %
0.31%
Top 10 Hldgs %
39.53%
Holding
188
New
24
Increased
37
Reduced
34
Closed
37

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$508M
2
CRM icon
Salesforce
CRM
+$266M
3
NOW icon
ServiceNow
NOW
+$264M
4
SPGI icon
S&P Global
SPGI
+$246M
5
SHW icon
Sherwin-Williams
SHW
+$212M

Sector Composition

Rank Sector Weight
1 Healthcare 33.98%
2 Technology 14.71%
3 Financials 12.17%
4 Communication Services 7.05%
5 Industrials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLX icon
151
Amylyx Pharmaceuticals
AMLX
$2.54B
-1,150,221
Closed -$3.73M
ANAB icon
152
AnaptysBio
ANAB
$1.68B
-183,876
Closed -$6.16M
ASND icon
153
Ascendis Pharma A/S
ASND
$16.8B
-1,400
Closed -$209K
BEKE icon
154
KE Holdings
BEKE
$18.8B
-4,740,833
Closed -$94.4M
BYND icon
155
Beyond Meat
BYND
$277M
-19,000
Closed -$129K
CNC icon
156
Centene
CNC
$32.5B
-614,917
Closed -$46.3M
CYTK icon
157
Cytokinetics
CYTK
$10.4B
-102,400
Closed -$5.41M
HWM icon
158
Howmet Aerospace
HWM
$112B
-1,514,339
Closed -$152M
IWM icon
159
PUT
iShares Russell 2000 ETF
IWM
$83B
-1,000,000
Closed -$221M
LU icon
160
Lufax Holding
LU
$1.3B
-15,000
Closed -$52.4K
NOW icon
161
ServiceNow
NOW
$129B
-1,475,250
Closed -$264M
PCVX icon
162
Vaxcyte
PCVX
$8.64B
-28,000
Closed -$3.2M
RARE icon
163
Ultragenyx Pharmaceutical
RARE
$2.55B
-4,000
Closed -$222K
RGTIW icon
164
Rigetti Computing Warrants
RGTIW
$181M
-22,675
Closed -$2.08K
RNAM
165
DELISTED
Avidity Biosciences
RNAM
-5,000
Closed -$230K
SHW icon
166
Sherwin-Williams
SHW
$89.8B
-555,950
Closed -$212M
SPGI icon
167
S&P Global
SPGI
$120B
-475,334
Closed -$246M
TAL icon
168
TAL Education Group
TAL
$6.87B
-1,365,000
Closed -$16.2M
THC icon
169
Tenet Healthcare
THC
$21.1B
-692,442
Closed -$115M
TMDX icon
170
Transmedics
TMDX
$2.91B
-44,000
Closed -$6.91M
VTYX
171
DELISTED
Ventyx Biosciences
VTYX
-3,170,000
Closed -$6.91M
MGX icon
172
Metagenomi Therapeutics
MGX
$46.3M
-1,057,201
Closed -$2.29M
CTLT
173
DELISTED
CATALENT, INC.
CTLT
-8,394,000
Closed -$508M
GHIXW
174
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
-166,664
Closed -$14.6K
IVCP
175
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
-300,000
Closed -$3.31M

Similar funds

Farallon Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Farallon Capital Management held 188 positions worth $22.8B, down 0.02% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management's Q4 2024 filing shows 24 new, 37 increased, 34 reduced and 37 closed positions. Its largest new stake was Autodesk: 1,841,800 shares worth $544M. The largest sale was CATALENT, INC., an estimated $508M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q4 2024 buy was Autodesk: 1,841,800 shares worth $544M.
  • Farallon Capital Management added most to Discover Financial Services in Q4 2024, an estimated $580M increase.
  • Farallon Capital Management's biggest Q4 2024 reduction was Salesforce, cutting an estimated $266M.
  • Farallon Capital Management fully exited CATALENT, INC. in Q4 2024, selling an estimated $508M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $22.8B portfolio in Q4 2024.
  • Farallon Capital Management opened 24 new positions and closed 37 in Q4 2024.
  • Farallon Capital Management's portfolio value fell 0.02% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.